Liver Failure: Clinical Trials

13 trials for Liver Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 terminated. 13 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable13Terminated 13

Follow Liver Failure: new trials by email Literature Review of Liver Failure trials Research Report on Liver Failure

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
Cycle ergometry - Liver Cirrhoses, Liver Failure
Not applicableTerminatedMedical College of Wisconsin972019-11-102024-03-20
Comparative Trial of Home-Based Palliative Care
Tech-supported HBPC, Standard HBPC - Cancer, Chronic Obstructive Pulmonary Disease
Not applicableTerminatedKaiser Permanente39992019-01-072020-02-20
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation
Esophageal cooling/warming device, Mild hypothermia, Normothermia - Cirrhosis, End Stage Liver Disease
Not applicableTerminatedUniversity of California, San Francisco1752018-07-072025-05-16
BRIDGE Device for Post-operative Pain Control
BRIDGE device - Liver Failure, Liver Diseases, Alcoholic
Not applicableTerminatedDuke University272018-02-122026-05-29
Pulmonary Rehabilitation in End-Stage Liver Disease
Pulmonary Rehabilitation Exercise, Home Based Exercise - End Stage Liver Disease
Not applicableTerminatedMayo Clinic42018-02-012024-12-12
To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
Peg GCSF, 20% Albumin, Nutrition - Acute on Chronic Liver Failure
Not applicableTerminatedInstitute of Liver and Biliary Sciences, India142016-05-012018-02-06
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Leukapheresis - End Stage Liver Disease
Not applicableTerminatedNorthwestern University12014-07-012019-09-25
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Rifaximin - Hepatic Encephalopathy
Not applicableTerminatedNYU Langone Health102012-09-012017-08-04
Liver Function Assessment - Feasibility and Dosing Study
ICG Dye - Hepatic Failure
Not applicableTerminatedCardiox Corporation572012-09-012016-01-15
Intraoperative Dialysis in Liver Transplantation
Continuous renal replacement therapy (CRRT), Standard intraoperative support - Liver Failure, Acute Kidney Disease
Not applicableTerminatedUniversity of Alberta322012-05-012017-02-07
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
Hepa Wash, Standard Medical Therapy - Liver Dysfunction, Critical Illness
Not applicableTerminatedHepa Wash GmbH72010-09-012019-07-09
Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units
ADVOS (Hepa Wash), Standard Medical Therapy - Acute on Chronic Hepatic Failure
Not applicableTerminatedHepa Wash GmbH142010-09-012019-07-05
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Lactose-free milk, Whole milk - Hepatic Encephalopathy, Liver Cirrhosis
Not applicableTerminatedCoordinación de Investigación en Salud, Mexico182010-07-012023-02-09

Narrower conditions

End Stage Liver Disease (4)  ·  Hepatic Encephalopathy (2)  ·  Hepatic Insufficiency (2)  ·  Liver Cirrhosis (2)  ·  Liver Diseases (2)  ·  Acute Kidney Injury (1)  ·  Acute-On-Chronic Liver Failure (1)  ·  Carcinoma, Hepatocellular (1)  ·  Critical Illness (1)  ·  Dementia (1)  ·  Fibrosis (1)  ·  Frailty (1)  ·  Heart Failure (1)  ·  Hepatitis B (1)

Broader conditions

Digestive System Diseases (13)  ·  Hepatic Insufficiency (11)  ·  Liver Diseases (11)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Nervous System Diseases (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Disease Attributes (3)  ·  Fibrosis (3)  ·  Signs and Symptoms (3)  ·  Alcohol-Induced Disorders (2)  ·  Alcohol-Related Disorders (2)  ·  Brain Diseases, Metabolic (2)

Interventions

Albumins (1)  ·  Continuous Renal Replacement Therapy (1)  ·  Hypothermia, Induced (1)  ·  Leukapheresis (1)  ·  Meropenem (1)  ·  Nutritional Status (1)  ·  Rifaximin (1)  ·  Terlipressin (1)

Sponsors

Hepa Wash GmbH (2)  ·  Cardiox Corporation (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Duke University (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Kaiser Permanente (1)  ·  Mayo Clinic (1)  ·  Medical College of Wisconsin (1)  ·  NYU Langone Health (1)  ·  Northwestern University (1)  ·  University of Alberta (1)  ·  University of California, San Francisco (1)

Countries

United States (7)  ·  Germany (2)  ·  Canada (1)  ·  India (1)  ·  Mexico (1)

Top investigators

Wolfgang Huber, PD Dr. (2)  ·  Alicia Mavis, MD (1)  ·  Huong Q Nguyen, PhD (1)  ·  Josh Levitsky, MD (1)  ·  Kymberly D Watt (1)  ·  Michael P Bokoch, MD, PhD (1)  ·  Michael W Jopling, M.D (1)  ·  Priyal Patel, MD (1)  ·  Richard A Mularski, MD (1)  ·  Samuel Sigal, M.D. (1)  ·  Sean M Bagshaw, MD, MSc (1)  ·  Segundo Moran, MD (1)

Results publications

PMID 28209134, PMID 31350701, PMID 31486724, PMID 34735285, PMID 35078873